Janette, like many patients with MODY, was diagnosed initially with Type 1 diabetes and treated with multiple insulin doses every day for decades. A genetic diagnosis was not made till 2011 when she read a paper about MODY in a newspaper and she was diagnosed with HNF4A diabetes and her insulin successfully replaced by the tablet gliclazide. Her daughter Alice was also diagnosed as having HNF4A diabetes and managed this well with lots of exercise and changing her diet to low carbohydrate; on this treatment approach she has enjoyed working and travelling all around the world. Janette realised the inheritance from generation to generation explained diabetes in her own children, her paternal aunt, and paternal nieces and nephews who had diabetes.
High birth weight and low blood glucose close to birth both occurred in Janette’s children; with the low glucose resulting in dramatic collapses that responded to feeding. The diagnosis of HNF4A explained why these had occurred as research from Exeter had shown that in utero fetus’ and baby’s that inherit the HNF4A mutation produce more insulin resulting in an increase in birth weight of 800 g on average and also a low blood glucose in the first few weeks after birth. These are really important to know about if HNF4A diabetes runs in your family.
More information about HNF4A can be found here:
https://www.diabetesgenes.org/what-is-mody/hepatic-nuclear-factor-4-alpha-hnf4a/
Specific information about pregnancy for mothers and fathers with HNF4A can be found here:
https://www.diabetesgenes.org/what-is-mody/information-on-pregnancy-and-hnf4a-diabetes/
The initial discovery was a very good example of listening to patients. We had known about the existence of HNF4A diabetes for nearly a decade before we realised about the big babies and low blood sugar after birth in HNF4A babies. Ewan Pearson, when studying for his PhD, was doing tricky clamp studies and had a long talk with one man who had HNF4A diabetes who during the 4 hour study started to explain his son had low blood sugar levels in early life. The medical studies on his son had shown he was making too much insulin. If there was too much insulin after birth it was likely there was too much fetal insulin and this would lead to a higher birthweight. When Ewan analysed this data for birthweight there was a striking increase in the babies who had inherited the HNF4A change. This was confirmed in a large study of all the HNF4A MODY patients that had been diagnosed by the Exeter lab. These results were published in this paper:
https://journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed.0040118
For pregnancy when either the mother or the father has HNF4A MODY there is a 50% chance the fetus will inherit the genetic change and as a result be on average 800g heavier. This increase is very large and means there may be problems associated with delivery. This means it is crucial that there are regular scans in the last third of pregnancy, this will happen already in diabetes pregnancy but not when the father has HNF4A MODY and the mother has normal glucose. The detection of whether the fetus is affected will greatly help decide on the timing of delivery to avoid macrosomia (dangerously large babies) and also to know if a paediatrician should be present at the birth in case of dangerously low blood sugar after birth. The Exeter genetics team have developed a blood test, available on the NHS in England, that takes blood from mothers ideally between 12-26 weeks pregnancy and allows very accurate (>95% accurate) prediction of whether the fetus has inherited the genetic change. This allows much better management of pregnancy.
To find out about this test look here: